Membranous nephropathy after use of UK-manufactured skin creams containing mercury

QJM: An International Journal of Medicine

Volumn 104, Issue 10, 2011, Pages 893-896

  Chakera, A ^a   Lasserson, D ^b   Beck, L H ^c   Roberts, I S D ^d   Winearls, C G ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALFACALCIDOL; ANTIANDROGEN; CREATININE; DERMATOLOGICAL AGENT; MERCURY; OMEPRAZOLE; VITAMIN D;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PEPTIC ULCER; PERIORBITAL EDEMA; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; UNITED KINGDOM; VITAMIN D DEFICIENCY;

EID: 79951628726     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq209     Document Type: Article

References (18)

1. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338:1202-11.
2. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997; 30:621-31.
3. Davison AM. Oxford Textbook of Clinical Nephrology. 3rd edn. Oxford, Oxford University Press, 2005.
4. Beck LH, Jr, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11-21.
5. Lamkin M. Racist appearance standards and the enhancements that love them: norman daniels and skin-lightening cosmetics. Bioethics 2009. PMID: 19747347 Advanced online publication 11 September 2009.
6. Yetunde MO, Ayesha OA, Dan A, Tahir M, Ngozi A, Shola A, et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol 2008; 47:344-53.
7. Oliveira DB, Foster G, Savill J, Syme PD, Taylor A. Membranous nephropathy caused by mercury-containing skin lightening cream. Postgrad Med J 1987; 63:303-4.
8. Soo YO, Chow KM, Lam CW, Lai FM, Szeto CC, Chan MH, et al. A whitened face woman with nephrotic syndrome. Am J Kidney Dis 2003; 41:250-3.
9. Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 2010; 21:697-704.
10. Ponticelli C. Membranous nephropathy. J Nephrol 2007; 20:268-87.
11. Haas M. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis 1994; 23:358-64.
12. Li SJ, Zhang SH, Chen HP, Zeng CH, Zheng CX, Li LS, et al. Mercury-induced membranous nephropathy: clinical and pathological features. Clin J Am Soc Nephrol 2010; 5: 439-444.
13. Havarinasab S, Hultman P. Alteration of the spontaneous systemic autoimmune disease in (NZB x NZW)F1 mice by treatment with thimerosal (ethyl mercury). Toxicol Appl Pharmacol 2006; 214:43-54.
14. Bigazzi PE, Kosuda LL, Hannigan MO, Whalen B, Greiner DL. Lack of graft-versus-host-like pathology in mercury-induced autoimmunity of Brown Norway rats. Clin Immunol 2003; 109:229-37.
15. Pusey CD, Bowman C, Morgan A, Weetman AP, Hartley B, Lockwood CM. Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat. Clin Exp Immunol 1990; 81:76-82.
16. Rendon MI, Gaviria JI. Review of skin-lightening agents. Dermatol Surg 2005; 31:886-9.
17. Pelclova D, Lukas E, Urban P, Preiss J, Rysava R, Lebenhart P, et al. Mercury intoxication from skin ointment containing mercuric ammonium chloride. Int Arch Occup Environ Health 2002; 75:S54-9.
18. Galber E, Roe S. FDA to investigate skin creams for mercury. Chicago Tribune 19 May 2010; 1.